Portfolio company
MONCYTE Health
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
1 investor
Sectors
About
This company develops diagnostic tests to personalise cholesterol-lowering treatments for clinicians and pharmaceutical firms to prevent cardiovascular disease.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
PocDoc
PocDoc develops app-based diagnostic kits for cardiovascular and metabolic disease testing, serving individuals and healthcare providers.
MedLea
This digital health company develops a digital twin platform to support diagnosis and prognosis of cardiorespiratory disorders for personalised medicine patients.
Staten Biotechnology
This company develops monoclonal antibody therapies for patients with dyslipidaemia to reduce cardiovascular risk and lower triglyceride levels.
Cardisio
This company develops non-invasive screening technology using artificial intelligence and vectorcardiography to detect heart diseases for healthcare professionals and clinical practices.
Everlab
This company develops an AI-powered preventative care platform providing diagnostic testing and personalised health plans for individuals and corporate employees.
Molecular Stethoscope
This company develops blood-based liquid biopsy tests that analyse cell-free messenger RNA to help clinicians and researchers detect and monitor diseases.
MetaSight
MetaSight Diagnostics develops multi-omics liquid biopsy tests for the early detection of chronic and acute diseases for healthcare providers and patients.
SkylineDx
This company develops molecular diagnostic tests to help healthcare professionals personalise treatment decisions for patients with oncology and inflammatory diseases.
